1/12
05:45 pm
bbnx
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
Medium
Report
INVESTOR ALERT: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Beta Bionics
1/12
04:55 pm
bbnx
Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
Medium
Report
Securities Fraud Investigation Into Beta Bionics, Inc. (BBNX) Announced – Investors Who Lost Money Urged To Contact The Law Offices of Frank R. Cruz
1/12
07:15 am
bbnx
Beta Bionics, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – BBNX
High
Report
Beta Bionics, Inc. Investigated on Behalf of Investors - Contact the DJS Law Group to Discuss Your Rights – BBNX
1/10
05:23 pm
bbnx
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
High
Report
BBNX Investors Have Opportunity to Join Beta Bionics, Inc. Fraud Investigation with the Schall Law Firm
1/10
01:07 am
bbnx
High
Report
1/9
09:02 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
High
Report
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at Lake Street Capital.
1/9
09:00 am
bbnx
Beta Bionics (NASDAQ:BBNX) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating.
High
Report
Beta Bionics (NASDAQ:BBNX) was downgraded by analysts at Bank of America Corporation from a "buy" rating to a "neutral" rating.
1/8
04:56 pm
bbnx
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics [Yahoo! Finance]
High
Report
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics [Yahoo! Finance]
1/8
04:04 pm
bbnx
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
High
Report
Beta Bionics Announces Preliminary, Unaudited Fourth Quarter 2025 Topline Financial Results and Key Metrics
1/5
08:33 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its price target raised by analysts at Bank of America Corporation from $30.00 to $33.00. They now have a "buy" rating on the stock.
Low
Report
Beta Bionics (NASDAQ:BBNX) had its price target raised by analysts at Bank of America Corporation from $30.00 to $33.00. They now have a "buy" rating on the stock.
12/18
09:18 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its price target raised by analysts at Truist Financial Corporation from $32.00 to $37.00. They now have a "buy" rating on the stock.
Low
Report
Beta Bionics (NASDAQ:BBNX) had its price target raised by analysts at Truist Financial Corporation from $32.00 to $37.00. They now have a "buy" rating on the stock.
12/16
07:08 am
bbnx
Beta Bionics (NASDAQ:BBNX) was given a new $28.00 price target on by analysts at Robert W. Baird.
Low
Report
Beta Bionics (NASDAQ:BBNX) was given a new $28.00 price target on by analysts at Robert W. Baird.
12/8
07:45 am
bbnx
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
Medium
Report
Beta Bionics to Pre-Announce Topline Fourth Quarter 2025 Financial Results the Week of January 5, 2026
11/14
01:10 pm
bbnx
Beta Bionics (NASDAQ:BBNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
Low
Report
Beta Bionics (NASDAQ:BBNX) had its "sell (d-)" rating reaffirmed by analysts at
Weiss Ratings.
11/3
04:08 pm
bbnx
Beta Bionics Announces Participation at Upcoming Investor Conferences
Low
Report
Beta Bionics Announces Participation at Upcoming Investor Conferences
11/1
01:05 am
bbnx
10/30
09:10 am
bbnx
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10 [Yahoo! Finance]
Low
Report
Beta Bionics, Inc. (NASDAQ:BBNX) Released Earnings Last Week And Analysts Lifted Their Price Target To US$28.10 [Yahoo! Finance]
10/29
10:08 am
bbnx
Beta Bionics (NASDAQ:BBNX) was given a new $32.00 price target on by analysts at Truist Financial Corporation.
Low
Report
Beta Bionics (NASDAQ:BBNX) was given a new $32.00 price target on by analysts at Truist Financial Corporation.
10/29
10:08 am
bbnx
Beta Bionics (NASDAQ:BBNX) was given a new $23.00 price target on by analysts at Robert W. Baird.
Medium
Report
Beta Bionics (NASDAQ:BBNX) was given a new $23.00 price target on by analysts at Robert W. Baird.
10/29
09:36 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $32.00 price target on the stock, up previously from $26.00.
Medium
Report
Beta Bionics (NASDAQ:BBNX) had its "overweight" rating reaffirmed by analysts at Piper Sandler. They now have a $32.00 price target on the stock, up previously from $26.00.
10/29
09:05 am
bbnx
Beta Bionics (NASDAQ:BBNX) was given a new $31.00 price target on by analysts at Stifel Nicolaus.
Medium
Report
Beta Bionics (NASDAQ:BBNX) was given a new $31.00 price target on by analysts at Stifel Nicolaus.
10/29
09:04 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
Medium
Report
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at The Goldman Sachs Group, Inc..
10/29
09:04 am
bbnx
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at Lake Street Capital. They now have a $35.00 price target on the stock.
Medium
Report
Beta Bionics (NASDAQ:BBNX) had its "buy" rating reaffirmed by analysts at Lake Street Capital. They now have a $35.00 price target on the stock.
10/28
04:02 pm
bbnx
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
Medium
Report
Beta Bionics Reports Third Quarter 2025 Financial Results and Raises Full Year 2025 Guidance
10/21
08:03 am
bbnx
Beta Bionics (NASDAQ:BBNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $26.00 price target on the stock.
Low
Report
Beta Bionics (NASDAQ:BBNX) is now covered by analysts at Stifel Nicolaus. They set a "buy" rating and a $26.00 price target on the stock.